Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.41 USD | +4.23% | +4.06% | -54.02% |
Apr. 03 | Stifel Cuts Price Target on Verve Therapeutics to $40 From $56, Maintains Buy Rating | MT |
Apr. 02 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 13.01M | Sales 2025 * | 10.02M | Capitalization | 538M |
---|---|---|---|---|---|
Net income 2024 * | -226M | Net income 2025 * | -254M | EV / Sales 2024 * | 7.54 x |
Net cash position 2024 * | 440M | Net cash position 2025 * | 204M | EV / Sales 2025 * | 33.3 x |
P/E ratio 2024 * |
-2.19
x | P/E ratio 2025 * |
-2.1
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.38% |
Latest transcript on Verve Therapeutics, Inc.
1 day | +4.23% | ||
1 week | +4.06% | ||
Current month | +6.66% | ||
1 month | -26.15% | ||
3 months | -41.78% | ||
6 months | -58.86% | ||
Current year | -54.02% |
Managers | Title | Age | Since |
---|---|---|---|
Sekar Kathiresan
FOU | Founder | 52 | 17-12-31 |
Allison Dorval
DFI | Director of Finance/CFO | 48 | 21-11-28 |
Andrew Ashe
PSD | President | 57 | 18-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Burt Adelman
FOU | Founder | 71 | 17-12-31 |
Lonnel Coats
BRD | Director/Board Member | 58 | 22-08-07 |
Michael MacLean
BRD | Director/Board Member | 58 | 21-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.13% | 2 M€ | -25.75% | ||
3.54% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 6.41 | +4.23% | 1,394,807 |
24-05-02 | 6.15 | +2.50% | 949,617 |
24-05-01 | 6 | -0.17% | 1,764,706 |
24-04-30 | 6.01 | -3.99% | 1,022,039 |
24-04-29 | 6.26 | +1.62% | 933,216 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.02% | 538M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- VERV Stock